Literature DB >> 25806198

Incomplete intrapulmonary lymph node retrieval after routine pathologic examination of resected lung cancer.

Marc Riquet1, Pierre Mordant1.   

Abstract

Entities:  

Year:  2013        PMID： 25806198      PMCID： PMC4367643          DOI： 10.3978/j.issn.2218-6751.2012.09.02

Source DB:  PubMed          Journal:  Transl Lung Cancer Res        ISSN： 2218-6751


× No keyword cloud information.
  3 in total

1.  Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma.

Authors:  T E Sawyer; J A Bonner; P M Gould; R L Foote; C Deschamps; C M Lange; H Li
Journal:  Ann Thorac Surg       Date:  1999-10       Impact factor: 4.330

2.  Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study.

Authors:  Gilbert Massard; Xavier Ducrocq; Evgenia A Kochetkova; Vladimir A Porhanov; Marc Riquet
Journal:  Eur J Cardiothorac Surg       Date:  2006-05-24       Impact factor: 4.191

3.  Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.

Authors:  Ajeet Gajra; Nancy Newman; Gary P Gamble; Leslie J Kohman; Stephen L Graziano
Journal:  J Clin Oncol       Date:  2003-03-15       Impact factor: 44.544
  3 in total
  3 in total

Review 1.  Towards optimal pathologic staging of resectable non-small cell lung cancer.

Authors:  Raymond U Osarogiagbon; Gail E Darling
Journal:  Transl Lung Cancer Res       Date:  2013-10

2.  Lymph node metastases outside tumor-bearing lobes and/or segments in non-small cell lung cancer.

Authors:  Lu Han; Hui Jia; Pingping Song; Xibin Liu; Zhendan Wang; Dujian Zhang
Journal:  Front Med (Lausanne)       Date:  2022-08-30

3.  Adjuvant chemotherapy may improve outcome of patients with non-small-cell lung cancer with metastasis of intrapulmonary lymph nodes after systematic dissection of N1 nodes.

Authors:  Xing Wang; Shi Yan; Yaqi Wang; Xiang Li; Chao Lyu; Yuzhao Wang; Jia Wang; Shaolei Li; Lijian Zhang; Yue Yang; Nan Wu
Journal:  Chin J Cancer Res       Date:  2018-12       Impact factor: 5.087
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.